These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2895155)

  • 1. Neurohumoral profile in congestive heart failure: response to beta-blockade.
    Binkley PF; Lewe R; Lima J; Unverferth DV; Leier CV
    J Lab Clin Med; 1988 Apr; 111(4):393-8. PubMed ID: 2895155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
    J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurohumoral changes in patients with heart failure treated chronically with beta-blockers].
    Mattioli AV; Mattioli G
    Cardiologia; 1991 Jul; 36(7):549-56. PubMed ID: 1686421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and neurohumoral effects of the angiotensin II antagonist losartan in patients with heart failure.
    Dickstein K; Gottlieb S; Fleck E; Kostis J; Levine B; DeKock M; LeJemtel T
    J Hypertens Suppl; 1994 Jul; 12(2):S31-5. PubMed ID: 7965263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta-adrenergic blockers in congestive heart failure: pro et contra?].
    Trifunović SL; Pavlović K
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():44-50. PubMed ID: 18193810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and neurohumoral effects of ketanserin, a 5-HT2 receptor antagonist in patients with congestive heart failure.
    Majid PA; Morris WM; Sole MJ
    Can J Cardiol; 1987 Mar; 3(2):70-4. PubMed ID: 3567710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heart insufficiency treated with beta-blocking agents. Comparison of responders and non-responders].
    Mattioli AV; Parato VM; Vivoli D; Bergomi M
    Cardiologia; 1992 May; 37(5):337-43. PubMed ID: 1358443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential role of calcium antagonists in the management of congestive heart failure: initial experience with lacidipine.
    de Vries RJ; Dunselman PH
    J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S33-9. PubMed ID: 8852543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation.
    Kalman J; Buchholz C; Steinmetz M; Courtney M; Gass A; Lansman S; Kukin ML
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1212-7. PubMed ID: 8719469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beta blockers in heart insufficiency].
    Noll G
    Praxis (Bern 1994); 1995 Mar; 84(11):313-8. PubMed ID: 7724947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of atenolol as add-on therapy to fosinopril in heart failure.
    Pacher R; Hülsmann M; Berger R; Koller-Strametz J; Kos T; Frey B; Dukat A; Stanek B
    Wien Klin Wochenschr; 1997 Apr; 109(7):232-8. PubMed ID: 9141231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
    Yokota Y
    J Cardiol; 1996 Aug; 28(2):99-112. PubMed ID: 8814528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic and neurohumoral effects of ibopamine in patients with chronic congestive heart failure.
    López-Sendón J
    Cardiology; 1990; 77 Suppl 5():9-21. PubMed ID: 1980634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
    Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M
    Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic-inotropic response to beta-blocker with intrinsic sympathomimetic activity in patients with congestive cardiomyopathy.
    Binkley PF; Lewe RF; Lima JJ; Al-Awwa A; Unverferth DV; Leier CV
    Circulation; 1986 Dec; 74(6):1390-8. PubMed ID: 3536153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bucindolol on neurohormonal activation in congestive heart failure.
    Eichhorn EJ; McGhie AL; Bedotto JB; Corbett JR; Malloy CR; Hatfield BA; Deitchman D; Willard JE; Grayburn PA
    Am J Cardiol; 1991 Jan; 67(1):67-73. PubMed ID: 1670902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.